Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?

Blood. 2005 Jan 15;105(2):904; author reply 905. doi: 10.1182/blood-2004-08-3088.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Antineoplastic Agents / therapeutic use*
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myeloid / drug therapy*
  • Leukemia, Myeloid / metabolism
  • Piperazines / therapeutic use*
  • Proto-Oncogene Proteins c-kit / metabolism
  • Pyrimidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate
  • Proto-Oncogene Proteins c-kit